Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.2%

15 terminated/withdrawn out of 1271 trials

Success Rate

93.0%

+6.5% vs industry average

Late-Stage Pipeline

11%

139 trials in Phase 3/4

Results Transparency

5%

9 of 200 completed trials have results

Key Signals

345 recruiting9 with results7 terminated8 withdrawn

Enrollment Performance

Analytics

N/A
454(54.0%)
Phase 2
151(18.0%)
Phase 4
79(9.4%)
Phase 1
73(8.7%)
Phase 3
60(7.1%)
Early Phase 1
23(2.7%)
840Total
N/A(454)
Phase 2(151)
Phase 4(79)
Phase 1(73)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1271)

Showing 20 of 1271 trials
NCT07738315Phase 2Not Yet Recruiting

Elemene Liposomes in Endometrial Cancer

Role: collaborator

NCT07736040Not ApplicableNot Yet Recruiting

The Impact of Diabetes Remission on Aging

Role: lead

NCT07735975Not ApplicableNot Yet Recruiting

Effects and Mechanisms of Temporal Interference Stimulation (TIS) on Neuropathic Pain

Role: lead

NCT07549282Phase 4Not Yet Recruiting

Intranasal Dexmedetomidine and Perioperative Myocardial Injury

Role: lead

NCT07617844Recruiting

Multimodal mAgnetic Resonance imaGIng in Cardiovascular Disease

Role: lead

NCT04686097Not ApplicableRecruiting

Percutaneous Electrocoagulation Versus Sclerosing Foam for Patients With Incompetent Perforating Veins

Role: lead

NCT05584020Not ApplicableRecruiting

Arthroscopic Anterior Cruciate Ligament Repair Versus Reconstruction for Acute Anterior Cruciate Ligament Injury

Role: lead

NCT07719868Not ApplicableNot Yet Recruiting

TaVNS for Capsaicin-Induced Pain

Role: lead

NCT07716176Phase 3Recruiting

Auricular Point Stimulation Plus Dexamethasone Versus Standard Antiemetic Regimen for Nausea and Vomiting Caused by Docetaxel Plus Cyclophosphamide

Role: lead

NCT07667465Recruiting

Single-Lead ECG Conduction Interval Algorithm

Role: collaborator

NCT07716228Phase 3Recruiting

Auricular Point Stimulation Plus Dexamethasone Versus Standard Antiemetic Regimen for Nausea and Vomiting Caused by Gemcitabine Combined With Paclitaxel Protein-bound

Role: lead

NCT07716189Phase 3Recruiting

Auricular Point Stimulation Plus Dexamethasone Versus Standard Antiemetic Regimen for Nausea and Vomiting Caused by Trastuzumab Deruxtecan

Role: lead

NCT07667452Recruiting

AI-Optimized Single-Feature Recognition Model for Heart Failure

Role: collaborator

NCT07716670Not Yet Recruiting

Development and Prospective Validation of an AI-Based Diagnostic Model for Hepato-Pancreato-Biliary Diseases

Role: lead

NCT07714109Active Not Recruiting

Twelve-lead Wearable Holter,MRI,CT,X-ray,Echocardiography

Role: lead

NCT07707687Phase 2Recruiting

Safety and Efficacy of Eculizumab in High-risk TA-TMA

Role: collaborator

NCT07707869Not ApplicableActive Not Recruiting

Study of Probiotic Adjunctive Therapy for Decolonization of Carbapenem-Resistant Enterobacterales

Role: lead

NCT07707882Phase 2Not Yet Recruiting

Neoadjuvant Pimicotinib Combined With Surgery Versus Upfront Surgery for Diffuse Tenosynovial Giant Cell Tumor

Role: lead

NCT07692841Phase 3Recruiting

Single-Dose vs. Divided-Dose G-CSF for Stem Cell Mobilization in Healthy Allogeneic Donors

Role: collaborator

NCT06964906Phase 2Recruiting

Neoadjuvant High-Intensity Focused Ultrasound (HIFU) Combined With Toripalimab and Chemotherapy for ER-Positive /HER2-Negative Breast Cancer

Role: lead